These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8798772)

  • 21. Cyclosporin A blocks the expression of lymphotoxin alpha, but not lymphotoxin beta, in human peripheral blood mononuclear cells.
    Kuprash DV; Boitchenko VE; Yarovinsky FO; Rice NR; Nordheim A; Rühlmann A; Nedospasov SA
    Blood; 2002 Sep; 100(5):1721-7. PubMed ID: 12176893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase.
    Natoli G; Costanzo A; Moretti F; Fulco M; Balsano C; Levrero M
    J Biol Chem; 1997 Oct; 272(42):26079-82. PubMed ID: 9334169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.
    Alimzhanov MB; Kuprash DV; Kosco-Vilbois MH; Luz A; Turetskaya RL; Tarakhovsky A; Rajewsky K; Nedospasov SA; Pfeffer K
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9302-7. PubMed ID: 9256477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells.
    Hehlgans T; Müller P; Stopfer P; Männel DN
    Eur Cytokine Netw; 2003; 14(2):103-7. PubMed ID: 12957791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
    Kim YS; Nedospasov SA; Liu ZG
    Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.
    Browning JL; Miatkowski K; Sizing I; Griffiths D; Zafari M; Benjamin CD; Meier W; Mackay F
    J Exp Med; 1996 Mar; 183(3):867-78. PubMed ID: 8642291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
    Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
    J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.
    Roach DR; Briscoe H; Saunders BM; Britton WJ
    Infect Immun; 2005 Aug; 73(8):4787-92. PubMed ID: 16040991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant, soluble LIGHT (HVEM ligand) induces increased IL-8 secretion and growth arrest in A375 melanoma cells.
    Hehlgans T; Männel DN
    J Interferon Cytokine Res; 2001 May; 21(5):333-8. PubMed ID: 11429164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
    Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
    Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor.
    Martín-Vañó S; Miralles-Abella A; Castaño P; Hurtado-Genovés G; Aguilar-Ballester M; Herrero-Cervera A; Vinué A; Martínez-Hervás S; González-Navarro H
    Clin Investig Arterioscler; 2023; 35(1):1-11. PubMed ID: 35738949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of tumor necrosis factor alpha-mediated NFkappaB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G protein-linked receptor (TP) ligands.
    Ashton AW; Ware GM; Kaul DK; Ware JA
    J Biol Chem; 2003 Apr; 278(14):11858-66. PubMed ID: 12517920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury.
    Akhurst B; Matthews V; Husk K; Smyth MJ; Abraham LJ; Yeoh GC
    Hepatology; 2005 Feb; 41(2):327-35. PubMed ID: 15660390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor.
    Etemadi N; Holien JK; Chau D; Dewson G; Murphy JM; Alexander WS; Parker MW; Silke J; Nachbur U
    FEBS J; 2013 Nov; 280(21):5283-97. PubMed ID: 23815148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis.
    Maracle CX; Kucharzewska P; Helder B; van der Horst C; Correa de Sampaio P; Noort AR; van Zoest K; Griffioen AW; Olsson H; Tas SW
    Rheumatology (Oxford); 2017 Feb; 56(2):294-302. PubMed ID: 27864565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.
    Mordmüller B; Krappmann D; Esen M; Wegener E; Scheidereit C
    EMBO Rep; 2003 Jan; 4(1):82-7. PubMed ID: 12524526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphotoxin beta receptor signaling induces the chemokine CCL20 in intestinal epithelium.
    Rumbo M; Sierro F; Debard N; Kraehenbuhl JP; Finke D
    Gastroenterology; 2004 Jul; 127(1):213-23. PubMed ID: 15236187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.